Guangzhou Wondfo Biotech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 23.76%

Guangzhou Wondfo Biotech Co Ltd (300482) has an Asset Resilience Ratio of 23.76% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Guangzhou Wondfo Biotech Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.60 Billion
≈ $234.11 Million USD Cash + Short-term Investments

Total Assets

CN¥6.73 Billion
≈ $985.42 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Guangzhou Wondfo Biotech Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Guangzhou Wondfo Biotech Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Wondfo Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangzhou Wondfo Biotech Co Ltd (300482) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.60 Billion 23.76%
Total Liquid Assets CN¥1.60 Billion 23.76%

Asset Resilience Insights

  • Good Liquidity Position: Guangzhou Wondfo Biotech Co Ltd maintains a healthy 23.76% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Guangzhou Wondfo Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou Wondfo Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medacta Group SA
SW:MOVE
Medical Devices 0.86%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 5.73%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%

Annual Asset Resilience Ratio for Guangzhou Wondfo Biotech Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Wondfo Biotech Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 19.15% CN¥1.26 Billion
≈ $185.03 Million
CN¥6.60 Billion
≈ $966.03 Million
+0.90pp
2024-12-31 18.26% CN¥1.31 Billion
≈ $191.15 Million
CN¥7.15 Billion
≈ $1.05 Billion
+5.74pp
2023-12-31 12.52% CN¥722.45 Million
≈ $105.72 Million
CN¥5.77 Billion
≈ $844.58 Million
-2.37pp
2022-12-31 14.89% CN¥938.07 Million
≈ $137.27 Million
CN¥6.30 Billion
≈ $922.05 Million
+3.09pp
2021-12-31 11.79% CN¥572.73 Million
≈ $83.81 Million
CN¥4.86 Billion
≈ $710.56 Million
+9.41pp
2020-12-31 2.38% CN¥102.60 Million
≈ $15.01 Million
CN¥4.31 Billion
≈ $630.12 Million
-1.00pp
2019-12-31 3.38% CN¥99.50 Million
≈ $14.56 Million
CN¥2.94 Billion
≈ $430.80 Million
+4.04pp
2018-12-31 -0.66% CN¥-17.66 Million
≈ $-2.58 Million
CN¥2.69 Billion
≈ $393.85 Million
+2.28pp
2017-12-31 -2.94% CN¥-49.75 Million
≈ $-7.28 Million
CN¥1.69 Billion
≈ $248.00 Million
-2.93pp
2016-12-31 -0.01% CN¥-69.38K
≈ $-10.15K
CN¥1.01 Billion
≈ $147.17 Million
+0.00pp
2015-12-31 -0.01% CN¥-60.83K
≈ $-8.90K
CN¥798.57 Million
≈ $116.86 Million
--
pp = percentage points

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices
Market Cap
$1.33 Billion
CN¥9.06 Billion CNY
Market Cap Rank
#7875 Global
#1872 in China
Share Price
CN¥19.35
Change (1 day)
-4.30%
52-Week Range
CN¥16.07 - CN¥25.56
All Time High
CN¥92.01
About

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rhe… Read more